These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23117369)

  • 1. Management of dabigatran-induced anticoagulation in trauma and acute care surgery patients.
    Obeng-Gyasi S; Loor MM; Samotowka MA; Moorman ML
    J Trauma Acute Care Surg; 2012 Nov; 73(5):1064-9. PubMed ID: 23117369
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial critique.
    Pieracci FM
    J Trauma Acute Care Surg; 2012 Nov; 73(5):1069. PubMed ID: 23117370
    [No Abstract]   [Full Text] [Related]  

  • 3. When dabigatran and trauma collide.
    Huang GS; Chance EA
    Am Surg; 2013 Jan; 79(1):113-4. PubMed ID: 23317625
    [No Abstract]   [Full Text] [Related]  

  • 4. Dabigatran and its reversal with recombinant factor VIIa and prothrombin complex concentrate: a Sonoclot in vitro study.
    Sølbeck S; Nilsson CU; Engström M; Ostrowski SR; Johansson PI
    Scand J Clin Lab Invest; 2014 Oct; 74(7):591-8. PubMed ID: 24909158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated prothrombin complex concentrate for the prevention of dabigatran-associated bleeding.
    Wong H; Keeling D
    Br J Haematol; 2014 Jul; 166(1):152-3. PubMed ID: 24617554
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of cell-associated tissue factor concentration on the anticoagulant activity of dabigatran. A possible explanation for the reduced incidence of intracranial bleeding.
    Ammollo CT; Zaccaria F; Visino F; Testa S; Semeraro N; Colucci M
    Br J Haematol; 2015 Mar; 168(6):911-3. PubMed ID: 25283217
    [No Abstract]   [Full Text] [Related]  

  • 7. A modified prothrombin time to measure the anticoagulant activity of dabigatran.
    Visino F; Zaccaria F; Semeraro N; Colucci M
    Thromb Res; 2014 Dec; 134(6):1368-9. PubMed ID: 25294590
    [No Abstract]   [Full Text] [Related]  

  • 8. Acutely injured patients on dabigatran.
    Cotton BA; McCarthy JJ; Holcomb JB
    N Engl J Med; 2011 Nov; 365(21):2039-40. PubMed ID: 22111735
    [No Abstract]   [Full Text] [Related]  

  • 9. Thrombolysis treatment for acute ischaemic stroke in a patient on treatment with dabigatran.
    Matute MC; Guillán M; García-Caldentey J; Buisan J; Aparicio M; Masjuan J; Alonso de Leciñana M
    Thromb Haemost; 2011 Jul; 106(1):178-9. PubMed ID: 21505718
    [No Abstract]   [Full Text] [Related]  

  • 10. Dabigatran: a primer for neurosurgeons.
    Fugate JE; Rabinstein AA; McBane RD; Lanzino G
    World Neurosurg; 2013 Jan; 79(1):154-8. PubMed ID: 22722043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dabigatran and emergency operation on a peritonitis patient].
    Ilmakunnas M; Louhimo J; Lassila R
    Duodecim; 2012; 128(7):753-7. PubMed ID: 22612026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of FEIBA® in the correction of coagulation abnormalities induced by dabigatran.
    Khoo TL; Weatherburn C; Kershaw G; Reddel CJ; Curnow J; Dunkley S
    Int J Lab Hematol; 2013 Apr; 35(2):222-4. PubMed ID: 23020832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dabigatran as cause of severe gastrointestinal bleeding in a Jehovah's Witness patient].
    Holm J; Taskiran M
    Ugeskr Laeger; 2013 Feb; 175(6):334-6. PubMed ID: 23402236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dabigatran for thromboprophylaxis after robotic assisted laparoscopic prostatectomy: retrospective analysis of safety profile and effect on blood coagulation.
    Säily VM; Pétas A; Joutsi-Korhonen L; Taari K; Lassila R; Rannikko AS
    Scand J Urol; 2014 Apr; 48(2):153-9. PubMed ID: 23865436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dabigatran therapy: minor trauma injuries are no longer minor.
    Joseph B; Ditillo M; Pandit V; Aziz H; Sadoun M; Hays D; Davis K; Friese R; Rhee P
    Am Surg; 2014 Apr; 80(4):E116-8. PubMed ID: 24887656
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute management of bleeding in patients on novel oral anticoagulants.
    Siegal DM; Crowther MA
    Eur Heart J; 2013 Feb; 34(7):489-498b. PubMed ID: 23220847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dabigatran, bleeding, and the regulators.
    Moore TJ; Cohen MR; Mattison DR
    BMJ; 2014 Jul; 349():g4517. PubMed ID: 25056265
    [No Abstract]   [Full Text] [Related]  

  • 18. Performance of coagulation tests in patients on therapeutic doses of dabigatran: a cross-sectional pharmacodynamic study based on peak and trough plasma levels.
    Hawes EM; Deal AM; Funk-Adcock D; Gosselin R; Jeanneret C; Cook AM; Taylor JM; Whinna HC; Winkler AM; Moll S
    J Thromb Haemost; 2013 Aug; 11(8):1493-502. PubMed ID: 23718677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dabigatran: how the drug company withheld important analyses.
    Cohen D
    BMJ; 2014 Jul; 349():g4670. PubMed ID: 25055829
    [No Abstract]   [Full Text] [Related]  

  • 20. Beyond warfarin: the new generation of oral anticoagulants and their implications for the management of dental patients.
    Firriolo FJ; Hupp WS
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Apr; 113(4):431-41. PubMed ID: 22668425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.